{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:32:24Z","timestamp":1791261144994,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T00:00:00Z","timestamp":1461196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jare.2016.04.001","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T18:30:16Z","timestamp":1462041016000},"page":"719-726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Aromatase inhibitors induced autoimmune disorders in patients with breast cancer: A review"],"prefix":"10.1016","volume":"7","author":[{"given":"George","family":"Zarkavelis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristomenes","family":"Kollas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios","family":"Kampletsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilis","family":"Vasiliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evripides","family":"Kaltsonoudis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Drosos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein","family":"Khaled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Pavlidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jare.2016.04.001_b0005","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1468-3083.2010.03803.x","article-title":"Aromatase inhibitor-induced skin adverse reactions: exemestane-related cutaneous vasculitis","volume":"25","author":"Santoro","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"10.1016\/j.jare.2016.04.001_b0010","first-page":"14","article-title":"Drug-induced pruritic micropapular eruption: anastrozole, a commonly used aromatase inhibitor","volume":"15","author":"Bremec","year":"2009","journal-title":"Dermatol Online J"},{"issue":"3","key":"10.1016\/j.jare.2016.04.001_b0015","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000083798","article-title":"Subacute cutaneous lupus erythematosus associated with tamoxifen therapy: two cases","volume":"210","author":"Fumal","year":"2005","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.jare.2016.04.001_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-014-3150-0","article-title":"Tamoxifen-associated skin reactions in breast cancer patients: from case report to literature review","volume":"148","author":"Andrew","year":"2014","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.jare.2016.04.001_b0025","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1365-2133.2007.08367.x","article-title":"Anastrozole-induced subacute cutaneous lupus erythematosus","volume":"158","author":"Trancart","year":"2008","journal-title":"Br J Dermatol"},{"issue":"6250","key":"10.1016\/j.jare.2016.04.001_b0030","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.281.6250.1254","article-title":"Systemic lupus erythematosus induced by aminoglutethimide","volume":"281","author":"McCraken","year":"1980","journal-title":"Br Med J"},{"issue":"6","key":"10.1016\/j.jare.2016.04.001_b0035","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/096120339300200611","article-title":"Effect of aminoglutethimide on the activity of a case of connenctive tissue disorder with features of systemic lupus erythematosus","volume":"2","author":"Etherington","year":"1993","journal-title":"Lupus"},{"issue":"9 Pt 1","key":"10.1016\/j.jare.2016.04.001_b0040","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.lpm.2007.02.032","article-title":"Paclitaxel-induced lupus","volume":"36","author":"Lortholary","year":"2007","journal-title":"Presse Med"},{"issue":"4","key":"10.1016\/j.jare.2016.04.001_b0045","first-page":"818","article-title":"Docetaxel (Taxotere) induced subacute cutaneous lupus erythematosus: report of 4 cases","volume":"31","author":"Chen","year":"2004","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.jare.2016.04.001_b0050","first-page":"19259","article-title":"Taxane associated subacute cutaneous lupus erythematosus","volume":"19","author":"Marchetti","year":"2013","journal-title":"Dermatol Online J"},{"issue":"10","key":"10.1016\/j.jare.2016.04.001_b0055","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/archdermatol.2010.258","article-title":"Subacute cutaneous lupus erythematosus exacerbated or induced by chemotherapy","volume":"146","author":"Funke","year":"2010","journal-title":"Arch Dermatol"},{"issue":"2 Suppl. 1","key":"10.1016\/j.jare.2016.04.001_b0060","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jaad.2007.06.040","article-title":"Occurrence of subacute cutaneous lupus erythematosus after treatment with fluorouracil and capecitabine","volume":"59","author":"Weger","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jare.2016.04.001_b0065","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/jamadermatol.2013.4958","article-title":"Drug-induced subacute cutaneous lupus erythematosus \u2013 filling the gap in knowledge","volume":"149","author":"Callen","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.jare.2016.04.001_b0070","doi-asserted-by":"crossref","first-page":"664","DOI":"10.7326\/0003-4819-97-5-664","article-title":"Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus","volume":"97","author":"Sontheimer","year":"1982","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.jare.2016.04.001_b0075","first-page":"465","article-title":"A systematic review of drug-induced subacute cutaneous lupus erythematosus","volume":"164","author":"Lowe","year":"2011","journal-title":"Brit J Dermatol"},{"issue":"7","key":"10.1016\/j.jare.2016.04.001_b0080","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1186\/1756-0500-7-785","article-title":"Drug-induced subacute cutaneous lupus erythematosus associated with docetaxel chemotherapy: a case report","volume":"5","author":"Wong","year":"2014","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.jare.2016.04.001_b0085","first-page":"871","article-title":"Docetaxel-induced relapse of subacute cutaneous lupus erythematosus and chilblain lupus","volume":"1109","author":"Lebeau","year":"2013","journal-title":"J Dtsch Dermatol Ges"},{"issue":"15","key":"10.1016\/j.jare.2016.04.001_b0090","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/s12885-015-1385-8","article-title":"Autoantibodies in breast cancer sera are not epiphenomena and may participate in carcinogenesis","volume":"15","author":"Madrid","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jare.2016.04.001_b0095","first-page":"25","article-title":"Paraneoplastic subacute cutaneous lupus erythematosus: an underrecognized entity","volume":"91","author":"Evans","year":"2013","journal-title":"Cutis"},{"key":"10.1016\/j.jare.2016.04.001_b0100","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/archderm.1986.01660190043013","article-title":"Cutaneous paraneoplastic syndromes","volume":"122","author":"McLean","year":"1986","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jare.2016.04.001_b0105","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/ard.62.4.341","article-title":"Beneficial effects of the anti-estrogen tamoxifen on systemic lupus erythematosus of (NZB\u00d7NZW)F1 female mice are associated with specific reduction of IgG3 autoantibodies","volume":"62","author":"Sthoeger","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jare.2016.04.001_b0110","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0889-857X(05)70171-X","article-title":"Different roles of androgens and estrogens in the susceptibility to autoimmune rheumatic diseases","volume":"26","author":"Cutolo","year":"2000","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.jare.2016.04.001_b0115","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/1529-0131(199902)42:2<328::AID-ANR16>3.0.CO;2-#","article-title":"Estrogen enhancement of anti-ds-DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus","volume":"42","author":"Kanda","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jare.2016.04.001_b0120","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/clinids\/13.6.1139","article-title":"Estrogens and infection","volume":"13","author":"Styrt","year":"1991","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.jare.2016.04.001_b0125","first-page":"77","article-title":"Letrozole-induced necrotising leukocytoclastic small vessel vasculitis: first report of a case in the UK","volume":"16","author":"Pathmarajah","year":"2015","journal-title":"Int J Surgery"},{"issue":"2","key":"10.1016\/j.jare.2016.04.001_b0130","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/1078155213480535","article-title":"Cutaneous leukocytoclastic vasculitis associated with letrozole","volume":"20","author":"Digklia","year":"2014","journal-title":"J Oncol Pharm Pract"},{"issue":"1","key":"10.1016\/j.jare.2016.04.001_b0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clim.2008.07.001","article-title":"Cutaneous vasculitis in breast cancer treated with chemotherapy","volume":"129","author":"Wong","year":"2008","journal-title":"Clin Immunol"},{"issue":"4","key":"10.1016\/j.jare.2016.04.001_b0140","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/ard.2004.023150","article-title":"Cutaneous vasculitis developed in a patient with breast cancer undergoing aromatase inhibitor treatment","volume":"64","author":"Shoda","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.jare.2016.04.001_b0145","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jbspin.2010.05.016","article-title":"Rheumatoid arthritis and aromatase inhibitors","volume":"78","author":"Bertolini","year":"2011","journal-title":"Joint Bone Spine"},{"issue":"4","key":"10.1016\/j.jare.2016.04.001_b0150","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/ard.2006.066159","article-title":"Will steroidal aromatase inhibitors induce rheumatoid arthritis?","volume":"66","author":"Morel","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.jare.2016.04.001_b0155","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3899\/jrheum.080648","article-title":"Accelerated cutaneous nodulosis associated with aromatase inhibitor therapy in a patient with rheumatoid arthritis","volume":"36","author":"Chao","year":"2009","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.jare.2016.04.001_b0160","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3899\/jrheum.140367","article-title":"The effect of antiestrogen agents on risk of autoimmune disorders in patients with breast cancer","volume":"42","author":"Chen","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jare.2016.04.001_b0165","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2478\/v10007-012-0012-3","article-title":"Immunomodulatory effects of anti-estrogenic drugs","volume":"62","author":"Ray","year":"2012","journal-title":"Acta Pharm"},{"issue":"17","key":"10.1016\/j.jare.2016.04.001_b0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13058-015-0599-7","article-title":"Arthralgia among women taking aromatase inhibitors: is there a shared inflammatory mechanism with co-morbid fatigue and insomnia?","volume":"28","author":"Bauml","year":"2015","journal-title":"Breast Cancer Res"},{"issue":"5","key":"10.1016\/j.jare.2016.04.001_b0175","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/1758834015598536","article-title":"Skeletal adverse effects with aromatase inhibitors in early breast cancer: evidence to date and clinical guidance","volume":"7","author":"Servitja","year":"2015","journal-title":"Ther Adv Med Oncol"},{"issue":"2","key":"10.1016\/j.jare.2016.04.001_b0180","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/bcr2818","article-title":"Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management","volume":"13","author":"Gaillard","year":"2011","journal-title":"Breast Cancer Res"},{"issue":"11","key":"10.1016\/j.jare.2016.04.001_b0185","first-page":"2259","article-title":"Joint pain with aromatase inhibitors: abnormal frequency of Sj\u00f6gren\u2019s syndrome","volume":"34","author":"Laroche","year":"2007","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.jare.2016.04.001_b0190","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5606\/ArchRheumatol.2014.3429","article-title":"Letrozole-induced very early systemic sclerosis in a patient with breast cancer: a case report","volume":"29","author":"Pokhai","year":"2014","journal-title":"Arch Rheumatol"},{"key":"10.1016\/j.jare.2016.04.001_b0195","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1002\/art.21364","article-title":"Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation","volume":"52","author":"Felson","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jare.2016.04.001_b0200","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1756-185X.2010.01561.x","article-title":"Association between nonspecific skeletal pain and Vitamin D deficiency","volume":"13","author":"Heidari","year":"2010","journal-title":"Int J Rheum Dis"},{"issue":"6","key":"10.1016\/j.jare.2016.04.001_b0205","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/annonc\/mdt037","article-title":"Aromatase inhibitor-induced arthralgia: a review","volume":"24","author":"Niravath","year":"2013","journal-title":"Ann Oncol"},{"issue":"17","key":"10.1016\/j.jare.2016.04.001_b0210","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1200\/JCO.2014.59.5595","article-title":"Randomized multicenter placebo-controlled trial of omega-3 fatty acids for the control of aromatase inhibitor-induced musculoskeletal pain: SWOG S0927","volume":"33","author":"Hershman","year":"2015","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.jare.2016.04.001_b0215","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s12328-014-0512-4","article-title":"A case of anastrazole-related drug-induced autoimmune hepatitis","volume":"7","author":"Islam","year":"2014","journal-title":"Clin J Gastroenetrol"},{"issue":"11","key":"10.1016\/j.jare.2016.04.001_b0220","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-230X-11-32","article-title":"Anastrozole-related acute hepatitis with autoimmune features: a case report","volume":"31","author":"Inno","year":"2011","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1016\/j.jare.2016.04.001_b0225","first-page":"18","article-title":"Drug-induced lupus erythematosous","volume":"105","author":"Pretel","year":"2014","journal-title":"Atlas Dermosifiliorg"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123216300212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123216300212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:42:35Z","timestamp":1761856955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123216300212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S2090123216300212"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2016.04.001","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aromatase inhibitors induced autoimmune disorders in patients with breast cancer: A review","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2016.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Production and hosting by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}